US Patent Issued to Jiangsu Hengrui Medicine, SHANGHAI HENGRUI PHARMACEUTICAL on June 10 for "Indazole derivative, preparation method therefor, and pharmaceutical application thereof" (Chinese Inventors)

ALEXANDRIA, Va., June 18 -- United States Patent no. 12,325,696, issued on June 10, was assigned to Jiangsu Hengrui Medicine Co. Ltd. (Lianyungang, China) and SHANGHAI HENGRUI PHARMACEUTICAL Co. LTD. (Shanghai).

"Indazole derivative, preparation method therefor, and pharmaceutical application thereof" was invented by Xing Fan (Shanghai), Fanglong Yang (Shanghai), Jingjing Yan (Shanghai), Xiao Wu (Shanghai), Feng He (Shanghai) and Weikang Tao (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "An indazole derivative, a preparation method therefor, and a pharmaceutical application thereof. In particular, the present invention relates to an indazole derivative represented by general formula (I), a preparat...